About Us
Daewoong Group is a global healthcare group established in 1945 under the vision to 'manufacture high-quality pharmaceuticals and medical devices to enhance people’s health and create a healthy society'.
Area of Business
Orthopedic Industry / Wound care Industry / Aesthetic
Number of Employees worldwide
more than 3,500
Year of Foundation
1945
Sales Volume
1.4 B USD
Core Product
1. Mediclore: Thermo-sensitive Anti-Adhesion barrier Sol-Gel type
2. Novomax: Osteo-active Cervical & Lumbar Spacer
3. Novosis: E.coli derived rhBMP-2
4. DBM: Fiber type DBM
5. Spinal Implant: Pedicle screw, ACP, Cages..
Product Categories
Biomaterials
- Bone Graft Matrix
- Bone Substitute Material
- Synthetic Bone Graft Substitute
Fusion
- Anterior Cervical Discectomy and Fusion (ACDF)
- Fixation
- Lumbar
- Spine Fusion
Implants
- Allografts
- Biomaterials
- Bone Screws
- Cervical Plates
- Interbody Cages
- Interbody Spacers
- Pedicle Screws
Spine Biologics
- Allografts
- Bone Morphogenetic Proteins
- Bone Substitutes and Machined Bones
- Demineralized Bone Matrix